rs756258267

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PM1PP2BP4BS2

The NM_000166.6(GJB1):​c.811G>A​(p.Ala271Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000461 in 1,193,071 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A271S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000049 ( 0 hom. 15 hem. )

Consequence

GJB1
NM_000166.6 missense

Scores

1
7
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 4.28

Publications

1 publications found
Variant links:
Genes affected
GJB1 (HGNC:4283): (gap junction protein beta 1) This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]
GJB1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease X-linked dominant 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
  • X-linked progressive cerebellar ataxia
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a chain Gap junction beta-1 protein (size 282) in uniprot entity CXB1_HUMAN there are 180 pathogenic changes around while only 11 benign (94%) in NM_000166.6
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 135 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to Charcot-Marie-Tooth disease X-linked dominant 1, X-linked progressive cerebellar ataxia.
BP4
Computational evidence support a benign effect (MetaRNN=0.27343324).
BS2
High Hemizygotes in GnomAdExome4 at 15 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GJB1NM_000166.6 linkc.811G>A p.Ala271Thr missense_variant Exon 2 of 2 ENST00000361726.7 NP_000157.1 P08034A0A654ICJ7
GJB1NM_001097642.3 linkc.811G>A p.Ala271Thr missense_variant Exon 2 of 2 NP_001091111.1 P08034A0A654ICJ7
GJB1NM_001440770.1 linkc.811G>A p.Ala271Thr missense_variant Exon 3 of 3 NP_001427699.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GJB1ENST00000361726.7 linkc.811G>A p.Ala271Thr missense_variant Exon 2 of 2 1 NM_000166.6 ENSP00000354900.6 P08034

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111701
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000136
AC:
2
AN:
146739
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000161
Gnomad OTH exome
AF:
0.000262
GnomAD4 exome
AF:
0.0000490
AC:
53
AN:
1081370
Hom.:
0
Cov.:
31
AF XY:
0.0000427
AC XY:
15
AN XY:
351266
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26006
American (AMR)
AF:
0.00
AC:
0
AN:
33209
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19013
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29419
South Asian (SAS)
AF:
0.00
AC:
0
AN:
51935
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38717
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4117
European-Non Finnish (NFE)
AF:
0.0000612
AC:
51
AN:
833450
Other (OTH)
AF:
0.0000440
AC:
2
AN:
45504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111701
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
33867
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30711
American (AMR)
AF:
0.00
AC:
0
AN:
10539
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3527
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6081
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000377
AC:
2
AN:
53093
Other (OTH)
AF:
0.00
AC:
0
AN:
1510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.00000837
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease Uncertain:1
Oct 28, 2019
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Feb 26, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A271T variant (also known as c.811G>A), located in coding exon 1 of the GJB1 gene, results from a G to A substitution at nucleotide position 811. The alanine at codon 271 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Charcot-Marie-Tooth Neuropathy X Uncertain:1
Aug 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 271 of the GJB1 protein (p.Ala271Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GJB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 567218). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;T;T;T;T
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.75
.;.;.;.;T
M_CAP
Pathogenic
0.85
D
MetaRNN
Benign
0.27
T;T;T;T;T
MetaSVM
Uncertain
0.48
D
MutationAssessor
Benign
0.0
N;N;N;N;N
PhyloP100
4.3
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.19
N;.;N;.;N
REVEL
Uncertain
0.36
Sift
Benign
0.12
T;.;T;.;T
Sift4G
Benign
0.11
T;.;T;.;T
Polyphen
0.80
P;P;P;P;P
Vest4
0.17
MutPred
0.21
Gain of relative solvent accessibility (P = 0.0215);Gain of relative solvent accessibility (P = 0.0215);Gain of relative solvent accessibility (P = 0.0215);Gain of relative solvent accessibility (P = 0.0215);Gain of relative solvent accessibility (P = 0.0215);
MVP
0.89
MPC
1.2
ClinPred
0.21
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.18
gMVP
0.44
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756258267; hg19: chrX-70444368; API